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DOI 10.1016/j.str.2007.10.004‘‘The PSI is a national effort to
assemble a large collection of
protein structures in a high-
throughput operation.. The
long-range goal is to make the
atomic-level structures of most
proteins easily obtainable from
their corresponding DNA se-
quences.’’
Description of the mission of
the PSI, from its website.
The long-range goal thus stated is,
of course, unexceptionable. But, the
current state of our knowledge gives
us neither a clear idea of the route we
should take to get to this goal nor
a convincing outline of the means re-
quired. That is, unlike the original
long-range goal of the Human Ge-
nome Project—to determine the
sequence of a representative human
genome—we have no clear definition
of what is needed to make the atomic-
level structures of proteins accessible
from their sequences. I would even go
so far as to suggest that assembling
a large collection of protein structures
in a high-throughput operation is prob-
ably not on the critical path to solving
the structure-prediction problem.
Let’s Dissect the Mission
Statement Carefully
(1) What is meant by ‘‘most pro-
teins’’? Presumably it refers
to compactly folded protein do-
mains or similarly defined struc-
tural entities, as cataloged by
pfam, for example. But large
parts of many important pro-
teins have defined structure
only in the context of their as-
sociation with other proteins,
or with nucleic acids. The de-
fined structure thus acquired is1344 Structure 15, November 2007 ª2007functionally and evolutionarily
relevant, but it cannot be ob-
tained simply from the DNA se-
quence of the protein in ques-
tion. Fos and Jun are good
examples. The leucine zippers
are helical only when a hetero-
dimer forms; the basic regions
are helical only as the dimer
binds DNA; much of the rest of
both proteins appears to be un-
structured until bound by cofac-
tors such as CBP/p300 (Weiss
et al., 1990).
(2) If we accept ‘‘most compact
domains, as defined by sophis-
ticated sequence comparison’’
as the definition of ‘‘most pro-
teins’’ in the mission statement,
then there are still many rea-
sons to suppose that even
a large sampling of structures
will not achieve the goal of mak-
ing ‘‘atomic-level structures .
easily obtainable from their cor-
responding . sequences.’’ I
enumerate a few of those rea-
sons here. (a) A pilot experiment
has essentially been done, with
so far a negative answer. There
are a very large number of in-
dependent immunoglobulin (Ig)
folds in the database. Yet
when a new protein like Dscam
(the Down-Syndrome associ-
ated cell adhesion molecule)
comes along, with multiple Ig
domains, understanding its bio-
logical specificity still requires
structure determination (Hattori
et al., 2007; Meijers et al., 2007).
(b) Homology modeling can
only yield approximations (if of-
ten useful ones), as homologs
with modest sequence identity
can differ in structurally and
functionally significant ways in
many local features. (c) The im-Elsevier Ltd All rights reservedportant biology is often pre-
cisely in the deviations from
similarity and in the difficult-to-
model features that arise from
these deviations. Even if homol-
ogy modeling were more pow-
erful, it would be most likely to
stumble just where we most
need the answer. (Of course,
homology modeling is excep-
tionally useful, and we all look
forward to real improvements,
but knowing that a given resi-
due lies in the FG-loop of an Ig
fold and knowing that it projects
in such a way that it can interact
with some other residue are two
quite different levels of preci-
sion. The latter is required if
truly useful coordinates are to
be derived from DNA se-
quence.) For a further critique
of this aim, see Petsko, 2007.
(3) There is no clear path between
where we are and the goal,
given any definition of ‘‘most
proteins.’’ Let us suppose that
PSI were to succeed in produc-
ing a very large number of rea-
sonably well-determined pro-
tein structures. How would we
then get from that large data-
base to the stated goal, or to
any other ambitious and worthy
goal? As just argued, we can-
not be confident that computa-
tional methods will soon be
adequate to produce from such
a database new information
that is truly critical for important
biomedical discovery. Individ-
ual cases of useful discovery
can of course be cited, but not
on a scale commensurate with
the effort and cost of PSI. Un-
like the human genome project,
where one knew (from work with
genome segments and smaller,
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would do with the new in-
formation, here is a database
without a good paradigm for
what we will do with it. Indeed,
as my description of the Ig cor-
ner of protein ‘‘fold space’’ sug-
gests, there are lots of reason
for insecurity.
(4) Most proteins, at least in eu-
karyotes, work as parts of com-
plex, regulated assemblies. The
structural biology of these
assemblies makes use of our
knowledge of domain struc-
tures as building blocks but
then needs to visualize them in
diverse contexts. A reasonable
homology model for a particular
domain can certainly be useful,
for example, when interpreting
an intermediate-resolution den-
sity map from cryo-EM; but, the
specific structure generally
needs to be determined any-
way. For example, merely
knowing that Arp2 and Arp3
look like actin is not sufficient,
when trying to figure out how
to interpret cryo-EM maps
of the Arp2/3 complex in
branched actin filaments (see,
for example, Rodal et al., 2005).
Likewise, knowing about SH2,
SH3, and kinase domains indi-
vidually does not help at all in un-
derstanding autoinhibition of
Src or Abl (see Harrison, 2003).
Knowing about cyclins and ki-
nases individually does not help
work out how cyclins modulate
kinase activity in Cdk/cyclin
complexes (reviewed by Pavle-
tich, 1999), and so on.
Thus, the means are not there to
achieve the ends of PSI, however
desirable those ends might be in
principle. Structural biology cannot in
the usefully near future be turned
simply into computation. But many of
us might agree that a technology-
oriented initiative in structural biology
could nonetheless be a wise one, as
the more appropriate first steps to-
ward the lofty ends of the PSI. In that
perspective, let me redirect the dis-
cussion to the following question:
what should be the medium-termgoals of a technology-oriented initia-
tive in structural biology at NIGMS?
Here is a partial list of areas in which
most practicing structural biologists
would welcome technical advances,
because each of us faces daily many
of the problems they might address.
Positive answers to the following
questions would all be real advances,
requiring good new ideas, not just
routine development. (1) Protein ex-
pression: can in vitro synthesis really
work? Can nonnatural amino acids
be incorporated with good yield and
reliability? (2) Protein expression: can
one work out affordable and robust ro-
botic methods for generating nested
deletions and related variations on
expression constructs? (3) Protein ex-
pression: why is it difficult to express
eukaryotic membrane proteins in bac-
teria? (4) Methods for 2D crystalliza-
tion of membrane proteins: how can
we produce more routinely 2D crystals
of sufficient size and order for high-
resolution structure determination by
electron diffraction? (5) Experimental
methods of structure determination:
can RDCs or related measurements
generate a routine approach to molec-
ular replacement in NMR? (6) Experi-
mental and computational methods in
cryo-EM: what are the barriers to
getting to atomic resolution in single-
particle cryo-EM analysis? How can
partial structures (e.g., from crystal
structures of some subunits in a larger
complex or from partial chain traces)
be incorporated into a ‘‘refinement’’
scheme to improve a 3D reconstruc-
tion? (7) Computational methods: are
there good ideas for fundamental im-
provements in homology modeling?
(8) Computational methods: how can
we improve the simulation, visualiza-
tion, and analysis of conformational
change, given ‘‘snapshots’’ of a pro-
cess from crystallography or EM? To
this list I can add, as examples, at least
two more ‘‘routine’’ projects: improved
automation at synchrotron beamlines
and support for the next generation
of structure-determination software.
How should such a program be im-
plemented? Certainly not through
large centers, as the list above re-
quires the kind of innovation best stim-
ulated by distributed support of many
independent investigators. Methodsare most often developed in the
context of solving some particular
problem. I would therefore advocate
some mix of R01s, P01s, and related
investigator-initiated mechanisms,
supported by certain national facilities,
such as synchrotron beamlines, the
NMR center in NY, and so on. Centers
dedicated only to high-throughput
structure determination should not be
maintained. In connection with moder-
ate (6–9 A˚) resolution cryo-EM, a rea-
sonable library of domain structures
will be useful, but not on an urgent
timescale. It will be better to provide
facilities and expertise for crystallizing
and determining structures of relevant
domains in conjunction with grants
concerned with larger assemblies,
rather than in the current setting of
large-scale centers motivated by
throughput rather than by functional
context and intellectual contribution.
It is possible that some robotic appli-
cations (for example, generation of
expression vectors) could be done by
a facility for investigators supported
by the kind of overall program I have
suggested. Protein expression itself
(for individual funded projects) should
be the task of the individual research
groups. It cannot usefully be done by
a facility, as it must respond to specific
experimental needs and to real under-
standing of the likely properties of the
molecules being made.
In conclusion, here is a modest pro-
posal for a PSI-3, should organiza-
tional commitments and ‘‘political’’
considerations demand a program un-
der that rubric. (1) Create a budget set
aside for a technology-oriented initia-
tive in structural biology, along the
lines described in the previous para-
graph. I cannot guess an appropriate
dollar figure without further study, but
I suspect that a useful number would
be substantially less than the total
budget for PSI-2. Responses to
thoughtfully worded RFAs should be
evaluated by the regular study sec-
tions. (2) Some of the existing centers
have probably accumulated talented
and dedicated staff and expertise
and potentially valuable facilities. I pro-
pose that a suitable group look into
these resources (human and material)
and come up with a plan to transform
a few of them into NIGMS-funded
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the overall technology-oriented pro-
gram outlined above and in accord
with decisions about aspects usefully
centralized. Talented staff at centers
not being so transformed might be of-
fered opportunities to move to a loca-
tion destined to persist (just as certain
synchrotron beamline staff often move
as their talents are better deployed at
newer facilities).
Summary
(1) The means are not at hand to
achieve the ends of PSI, how-
ever desirable those ends might
be in principle.
(2) A technology-oriented initiative
in structural biology is nonethe-
less a useful idea.1346 Structure 15, November 2007 ª200(3) Such an initiative should be de-
signed to facilitate some
fundamental methodological
breakthroughs, of which I give
a partial (and necessarily opin-
ionated) list.
(4) As breakthroughs like these re-
quire innovation and imagina-
tion, the funding mechanism
should be a mix of R01 and
P01 grants, possibly supported
by a small number of national
facilities.
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